[ Price : $8.95]
FDA lifts a six-month clinical hold on Cortex Pharmaceuticals investigational drug Ampakine CX717 for treating Alzheimers disease....[ Price : $8.95]
Current and former members of FDAs drug safety advisory committee say there are major problems with the agencys approach to drug s...[ Price : $8.95]
FDA says New River Pharmaceuticals NRP104 candidate for once-daily treatment of ADHD in children six to 12 is approvable.[ Price : $8.95]
Federal Register Final rule: FDA approves a Merial Ltd. supplemental NADA for administering omeprazole to horses for preventing ga...[ Price : $8.95]
FDA approves a change to Roches Accutane and generic isotretinoin makers iPLEDGE risk management program to remove a prescribing r...[ Price : $8.95]
Wyeth Pharmaceuticals submits an NDA for Torisel, indicated for treating patients with advanced renal cell carcinoma.[ Price : $8.95]
FDA approves a revised medication guide to warn about major bleeding for patients taking Bristol-Myers Squibbs blood thinner Couma...[ Price : $8.95]
CDERs Office of Generic Drugs adopts an Office of New Drugs electronic file system for more efficient reviews and archiving.